期刊文献+

通心络有效干预阿司匹林抵抗现象的临床观察 被引量:12

Clinical study on interference of Tongxinluo for aspirin resistance.
原文传递
导出
摘要 目的探讨通心络与阿司匹林联合或替代治疗对血小板聚集率的影响。方法选取接受阿司匹林治疗的患者302例。根据血小板聚集率筛选阿司匹林抵抗患者。按时间顺序入组,以洗脱方式分组。停用阿司匹林2周,服通心络8粒+阿司匹林100mg/d,1个月,再停药2周,服通心络8粒/d,1个月。复查血小板聚集率。结果302例患者中58例存在阿司匹林抵抗,占19.2%。通心络+阿司匹林组与通心络组服药后1个月血小板聚集率均明显下降(均为P<0.05)。结论通心络可以降低血小板聚集率,对于阿司匹林抵抗患者,选用通心络治疗可以取得一定的疗效。 Objective To study the effect of combination of Tongxinluo and aspirin or supplementary therapy on platelet aggregation rate. Methods 302 cases treated with aspirin were selected according to platelet aggregation rate, who were divided by washing methods. 2 weeks later after aspirin was stopped, the patients were given Tongxinluo 8 tablets a day plus aspirin 100mg/d for 1 month, and then another 2 weeks later the patients were only given Tongxinluo 8/d for 1 month. The platelet aggregation rate was measured. Results Of 302 cases, 58 cases developed aspirin resistance ( 19.2% ). Platelet aggregation rate was significantly decreased after 1 month of appceation of tongxinluo in the two oroups(P 〈 0.05 for each). Conclusion Tongxinluo may reduce platelet aggregation rate and produce certain therapeutic effect for the patients with aspirin resistance.
出处 《中国综合临床》 北大核心 2006年第9期778-779,共2页 Clinical Medicine of China
关键词 阿司匹林抵抗 通心络 血小板聚集 Aspirin resistance Tongxinluo Platelet aggregation
  • 相关文献

参考文献11

  • 1Antiplatelet Trialist's Collaboration.Collaborative over view of randomized trial of antiplatelet the therapy Ⅲ.Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients[J].BM J,1994,308 (6 923):235-246.
  • 2Antiplatelet Trialist's Collaboration.Collaborative over view of randomized trial of antiplatelet therapy Ⅰ:Prevention of death,myocardial in fraction,and stroke by prolonged antiplatelet therapy in various categories of patients[J].BMJ,1994,308(6 921):81-106.
  • 3Patrono C,Coller B,Dalen JE,et al.Platelet-active drugs:the relation ships among dose,effectiveness,and side effects[J].Chest,1998,114(5 Suppl):470-488.
  • 4Grotemeyer KH,Scharafinski HW,Husstedt IW.Two-year followup of aspirin responder and aspirin non responder.A pilot-study including 180 post-stroke patients[J].Thromb Res,1993,71 (5):397-403.
  • 5Helgason CM,Bolin KM,Hoff JA,et al.Development of aspirin resistance in persons with previous ischemic stroke[J].Stroke,1994,25(12):2 331-2 336.
  • 6Gum PA,Kottke-Marchant K,Poggio ED,et al.Profile and prevalance of aspirin resistance in patients with cardiovascular disease[J].Am J Cardiol,2001,88(3):230-235.
  • 7王七月.通心络胶囊治疗心脑血管病150例临床观察[J].现代中西医结合杂志,2002,11(14):1328-1329. 被引量:4
  • 8富红梅.通心络胶囊对心血瘀阻及痰浊壅塞型胸痹疗效比较[J].中医药学刊,2003,21(3):364-364. 被引量:5
  • 9张强,杨丽红,乔鹏,崔天祥.通心络治疗不稳定型心绞痛68例临床观察[J].中国基层医药,2004,11(9):1080-1081. 被引量:8
  • 10廖名龙,郁杰,黄成斌.通心络胶囊治疗心血管疾病临床新进展[J].中国药物与临床,2002,2(4):257-257. 被引量:17

二级参考文献18

  • 1付生法,陆应麟,张朝山,陈坤.检测血管生长因子作用的鸡胚绒毛尿囊膜技术[J].军事医学科学院院刊,1993,17(4):294-297. 被引量:129
  • 2刘平,周建锋,胡义扬,刘成海,刘成.益气养阴诱导SMMC-7721肝癌细胞分化作用与意义[J].中国中医基础医学杂志,2000,6(8):29-34. 被引量:44
  • 3吕欣然,白林,朱广瑾,张莹,段岩平.蝎蜂毒肽对大鼠纤溶系统作用初探[J].基础医学与临床,1994,14(4):69-70. 被引量:18
  • 4方之贤 宋崇顺.医用中药药理学[M].北京:人民卫生出版社,1998.965.
  • 5Ross R. Cell biology and atherosclerosis. Annu Rev Physiol, 1995,57:791-804.
  • 6Li J, Brown LF, Hibberd MG, et al. VEGF, flk-l, and flt- 1 expression in a rat myocardial infarction modle of angiofenesis. Am J Physiol, 1996,270:H1 803-1 811.
  • 7Sakae Amagya, Kazumichi, Akira Miyake, et al. A new pharmacological testing method-Different effects of levamisole and the serum of mice orally treated with levamisole on mitogenic activity of lipopolysaceharide. J Chem Pharm Bull,1989,37(4):1 117-1 119.
  • 8高惠泽 殷柏松 赵曙光 等.糖尿病并发脑梗死在常规治疗基础上再加通心络胶囊疗效观察研究[J].中华医学创新论坛杂志,2001,2(3):43-43.
  • 9林朝胜,佟铭,赵凯,关绍义,刘莹.冠心病心绞痛发作与循环内皮素水平关系的探讨[J]中国实用内科杂志,1994(12).
  • 10张曼,周爱儒,汤健.血管发生和发展的分子机制[J].生理科学进展,1999,30(1):67-70. 被引量:26

共引文献109

同被引文献198

引证文献12

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部